Friends Annual Meeting 2018 – Panel 2 Whitepaper: Exploring the Use of Circulating Tumor DNA as a Monitoring Tool for Drug Development | November 16, 2018 Share
Friends Annual Meeting 2018 – Panel 1 Whitepaper: Exploring Whether A Synthetic Control Arm can be Derived from Historical Clinical Trials that Match Baseline Characteristics and Overall Survival Outcome of a Randomized Control Arm | November 16, 2018 Share
Broadening the Definition of Tolerability in Cancer Clinical Trials to Better Measure the Patient Experience | October 24, 2018 Share
Friends-Alexandria 7th Annual Blueprint for Breakthrough Forum White Paper – Research and Reimbursement in the Age of Precision Medicine | September 14, 2018 Share
Outdated Prescription Drug Labeling: How FDA-Approved Prescribing Information Lags Behind Real-World Clinical Practice | April 12, 2018 Share
Early Evaluation of Molecularly Targeted Therapies for Childhood and Adolescent Cancer | February 14, 2018 Share
Charting the Course for Precision Medicine: Adopting Consensus Analytical Standards and Streamlining Approval Pathways for Post-Market Modifications for NGS Tests in Oncology | December 13, 2017 Share
2017 Annual Meeting: Data Generation to Support Cross-labeling of Indications for Combination Products | December 12, 2017 Share
